Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis

Fredrick M. Wigley, Robert A. Wise, Robyn Miller, Barbara White Needleman, Robert Spence

Arthritis & Rheumatism · 1992 · 157 citations · 24 references

Concepts

Abstract

OBJECTIVE: To determine the clinical and serologic risk factors for digital ischemic events in patients with systemic sclerosis (SSc). METHODS: Retrospective review of clinical and laboratory data and review of current clinical status of 98 patients with SSc, seen between 1985 and 1990. RESULTS: Amputation of 1 or more digits due to ischemia occurred in 20.4% of the patients; 9.2% had multiple digit loss. Sclerodactyly alone and anticentromere antibody (ACA) were associated with loss of 1 or more digits. Age, smoking status, duration of disease, or duration of Raynaud's phenomenon were not predictive for loss of digits. CONCLUSION: Patients with limited SSc who are positive for ACA have an increased risk of major peripheral vascular occlusive disease.

References

24